In summary, IL33's biological functions in HCC, as indicated by GSEA, point towards its involvement in promoting cancer stemness, affecting tumour progression, modulating the immune microenvironment, and contributing to genomic instability. The gene discussed is IL33; the disease is hepatocellular carcinoma.